Skip to content

Clinical trials

Observational Sleep Apnea, Obstructive trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sleep Apnea, Obstructive Phase: Observational Country / region: United States Clear all

153 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20043
20053
20065
20075
20089
20098
20103
20118
20127
20137
20146
20156
20168
201712
20187
20199
20206
20217
20225
20234
202412
20253
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed90
Recruiting19
Unknown status13
Withdrawn9
Terminated7
Active, not recruiting7
Enrolling by invitation6
Not yet recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of California, San Diego7
Mayo Clinic6
Ohio State University6
University of Pennsylvania6
University of Michigan4
Children's Hospital Medical Center, Cincinnati3
Duke University3
Fisher and Paykel Healthcare3
Inspire Medical Systems, Inc.3
Tufts Medical Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sleep Apnea, Obstructive153
Sleep Apnea Syndromes33
Heart Failure6
Obesity6
Apnea4
Hypertension4
Respiratory Insufficiency4
Sleep Initiation and Maintenance Disorders4
Arrhythmias, Cardiac3
Atrial Fibrillation3

Trials

Showing 1 to 25 of 153. Each trial links to its page on Pharma Observatory.

53 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.